Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 13;51(6):2799-2809.
doi: 10.3906/sag-2101-276.

Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic

Güldane Cengiz Seval  1 , Pervin Topçuoğlu  1 , Taner Demirer  1
Affiliations
Review

Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic

Güldane Cengiz Seval et al. Turk J Med Sci. .

Abstract

Background/aim: The COVID-19 pandemic is a unique challenge to the care of patients with hematological malignancies. We aim to provide supportive guidance to clinicians making individual patients decisions during the COVID-19 pandemic, in particular during periods that access to healthcare resources may be limited.

Conclusion: This review also provides recommendations, which are convenient in evaluating indications for therapy, reducing therapy-associated immunosuppression, and reducing healthcare utilization in patients with specific hematological malignancies in the COVID-19 era. Specific decisions regarding treatment of hematological malignancies will need to be individualized, based on disease risk, risk of immunosuppression, rates of community transmission of SARS-CoV-2, and available local healthcare resources.

Keywords: COVID-19; SARS-CoV-2; hematological malignancies.

PubMed Disclaimer

Conflict of interest statement

All authors disclose no conflict of interest.

Similar articles

See all similar articles

References

    1. Mutnal MB, Arroliga AC, Walker K, Mohammad A, Brigmon MM, et al. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses. Journal of Medical Virology. 2020;92(10):2130–2138. doi: 10.1002/jmv.26010. - DOI - PMC - PubMed
    1. Ljungman P, Mikulska M, De la Camara R, Basak GW, Chabannon C, et al. European Society for Blood and Marrow Transplantation: the challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplantation. 2020;55(11):2071–2076. - PMC - PubMed
    1. Al Saleh AS, Sher T, Gertz MA. Multiple myeloma in the time of COVID-19. Acta Haematologica. 2020;143(5):410–416. doi: 10.1159/000507690. - DOI - PMC - PubMed
    1. Percival MEM, Lynch RC, Halpern AB, Shadman M, Cassaday RD, et al. Consideration for managing patients with hematologic malignancy during the COVID-19 pandemic: the Seattle strategy. JCO Oncology Practice. 2020;16(9):571–578. doi: 10.1200/OP.20.00241. - DOI - PMC - PubMed
    1. Gavillet M, Carr Klappert J, Spertini O, Blum S. Acute leukemia in the time of COVID-19. Leukemia Research. 2020;92:106353. doi: 10.1016/j.leukres.2020.106353. - DOI - PMC - PubMed

LinkOut - more resources